Mohan Maheswaran
Analyst · Citi.
So with about Gennum, I think we're in very good shape. We feel that the integration has gone quite well. Clearly, from a sales standpoint, we are now really, have one sales team that's selling the Gennum products and the Semtech products. There's a lot of sale synergies there in terms of customers, et cetera. From a strategy standpoint there's alignment, I would say, on the functional side, a lot of the integration of systems, et cetera, has gone very well. So I'm very, very pleased with how the Gennum acquisition and integration has gone. And that's clearly demonstrated in the results. The results are not an accident. The fact that we are generating record product revenues and record overall revenues and very good traction there I think is part of the reason why I'm comfortable saying that the acquisition integration has gone well. As it pertains to going forward, we've always had a strategy of growth and we look at organic and we look at external growth, and when the opportunity is there, we'll go look at that very carefully. I would say, though, and this is why we've been successful with acquisitions, is we focus a lot of attention on execution. And until we are comfortable that we're executing superbly well on all fronts, we won't pursue anything else. And so that's a key part of the overall strategy. The other aspect of acquisition is also the balance. We want to maintain the balance both from an end market standpoint and a product standpoint and a geographical standpoint. So that's also a critical piece of it. And then also the financial model. As you know, we have a very rigid financial model. We expect very good gross margins, very good operating margins. And at the moment, with the Gennum acquisition, we are not at the operating margins that we need to be, so we have some work to go there. So, yes, I think we will continue to look at acquisition, but it's not one of those things that I think we have to go do immediately. We can balance it with the growth of the market.